Resmed Inc. RMD

NYS: RMD | ISIN: US7611521078 16/06/2026

193,94 USD (+0,62%)

(+0,62%) 16/06/2026

Grafiek Resmed Inc.

Grafiek Resmed Inc.

1 dag1d 0,62%
1 week1w 0,81%
1 maand1m -5,00%
3 maanden3m -14,89%
6 maanden6m -20,04%
1 jaar1j -22,70%
5 jaar5j -18,32%

Resmed Inc. in het nieuws

Toon enkel gratis nieuws

1 juni 2026 · Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio · Persbericht

30 april 2026 · Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor · Persbericht

3 maart 2026 · Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach · Persbericht

3 september 2025 · Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority · Persbericht

27 augustus 2025 · Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds · Persbericht

21 augustus 2025 · Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs · Persbericht

18 augustus 2025 · Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio · Persbericht

15 mei 2025 · Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025 · Persbericht

1 mei 2025 · Resmed Acquires VirtuOx · Persbericht

21 april 2025 · Resmed Names Salli Schwartz as Chief Investor Relations Officer · Persbericht

Profiel Resmed Inc.

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.resmed.com

Hoofdzetel: San Diego, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe